Health

NHS will offer pembrolizumab cervical cancer drug in England


NHS England’s director of specialised commissioning and interim commercial medicines director, John Stewart, said: “After nearly 15 years without a new treatment for this type of advanced cervical cancer, this first immunotherapy marks a significant step forward that will provide hundreds of people with precious time with their loved ones.



READ SOURCE

Readers Also Like:  Kettering hospital ward accused of failing children rated inadequate

This website uses cookies. By continuing to use this site, you accept our use of cookies.